Sign In  |  Register  |  About Livermore  |  Contact Us

Livermore, CA
September 01, 2020 1:25pm
7-Day Forecast | Traffic
  • Search Hotels in Livermore

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:

Millions Struggle With Mental Illness As Post-Traumatic Stress Disorders On The Rise

Port Chester, NY (Newsworthy.ai) Tuesday Apr 25, 2023 @ 3:00 PM Central —

Recent news highlights the increasing prevalence and devastating effects of mental illness across the globe. While conditions such as depression and anxiety have received significant attention, experts warn against overlooking the growing challenges of post-traumatic stress disorder (PTSD).

According to research, PTSD can arise in individuals after experiencing a traumatic event, such as a natural disaster, a violent crime, or a military conflict. However, it is common for individuals to develop PTSD after experiencing long-term, low-level trauma, such as emotional abuse or neglect.

PMC understands that PTSD can be a very debilitating condition. Intrusive thoughts, nightmares, flashbacks related to the traumatic event, emotional numbing, avoidance of triggers, and hypervigilance characterize it. These symptoms can make it difficult to function day-to-day and impede one's quality of life.

Symptoms of PTSD can be challenging to identify and can arise anytime after a traumatic event. However, individuals need to seek support if they experience any of the following:

  • Intrusive thoughts or memories of the traumatic event
  • Flashbacks or nightmares
  • Avoidance of anything that triggers memories of the event
  • Feelings of guilt, shame, or anger
  • Hypervigilance or being constantly on edge

Despite the challenges individuals face with PTSD, there is hope for recovery. Seeking professional support and consistent self-care practices can help alleviate symptoms and improve overall well-being.

About PMC

At PMC Psychedelic Centers of America, we are leaders in the new field of psychedelic medicine and behavioral health. We use psychedelics (only as they are approved by the FDA) and conventional psychiatric medications to treat a variety of conditions, including treatment-resistant depression, anxiety, ADHD, PTSD, and OCD.



This press release is distributed by the Newsworthy.ai™ Press Release Newswire - News Marketing Platform™. Reference URL for this press release is here.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
Copyright © 2010-2020 Livermore.com & California Media Partners, LLC. All rights reserved.